{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:32:56Z","timestamp":1791268376863,"version":"4.1.0"},"reference-count":55,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.4155\/fmc.11.117","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T16:04:53Z","timestamp":1314893093000},"page":"1513-1521","source":"Crossref","is-referenced-by-count":296,"title":["Iminosugars as Therapeutic Agents: Recent Advances and Promising Trends"],"prefix":"10.1080","volume":"3","author":[{"given":"Robert J","family":"Nash","sequence":"first","affiliation":[{"name":"Phytoquest Limited, Plas Gogerddan, Aberystwyth, Ceredigion, SY23 3EB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, University of Toyama, Toyama930-0194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Yi","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, Chinese Academy of Science, Beijing100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W J","family":"Fleet","sequence":"additional","affiliation":[{"name":"Chemistry Research Laboratory, 12 Mansfield Road, University of Oxford, OxfordOX1 3TA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,9]]},"reference":[{"key":"e_1_3_2_3_1_1","unstructured":"Nash RJ WatsonAA WintersALet al. novel biologically-active alkaloids from British plants. In: Phytochemical Diversity: A Source of New Industrial Products. Wrigley SK Hayes M Thomas R Chrystal E (Eds). Royal Society of Chemistry Cambridge UK 106\u2013114 (1997)."},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"crossref","unstructured":"Watson AA NashRJ. Water soluble bioactive alkaloids. In: Biodiversity: New Leads for the Pharmaceutical and Agrochemical Industries. Wrigley SK Hayes MA Thomas R Chrystal EJT Nicholson N (Eds). Royal Society of Chemistry Cambridge UK 169\u2013204 (2000).","DOI":"10.1039\/9781847550231-00169"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9422(00)00451-9"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8522-3"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetasy.2009.02.048"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"crossref","unstructured":"Compain P MartinOR AsanoNet al. Iminosugars: from Synthesis to Therapeutic Applications. Compain P Martin OR (Eds). John Wiley & Sons Chichester UK 1\u2013467 (2007).","DOI":"10.1002\/9780470517437.ch1"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2010.08.017"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-381290-2.00004-5"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3078"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03192"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2010.02.018"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/np068054v"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2010.02.001"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2005.030.06.914820"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059030-00012"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-103"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2007.05.035"},{"key":"e_1_3_2_3_18_1","unstructured":"Zavesca\u00ae (miglustat) first treatment available in UK And Ireland for rare progressive Niemann\u2013Pick type C disease. Medical News Today 21July (2009)"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetlet.2010.05.131"},{"key":"e_1_3_2_3_20_1","first-page":"o2904","article-title":"Steviamine, a new class of indolizidine alkaloid [(1R,2S,3R,5R,8aR)-3-(Hydroxymethyl)-5- methyloctahydroindolizine-1,2-diol hydrobromide].","volume":"65","author":"Thompson AL","year":"2009","unstructured":"Thompson AL , MichalikA, NashRJet al. Steviamine, a new class of indolizidine alkaloid [(1R,2S,3R,5R,8aR)-3-(Hydroxymethyl)-5- methyloctahydroindolizine-1,2-diol hydrobromide]. Acta Cryst. E65, o2904\u2013o2905 (2009).","journal-title":"Acta Cryst."},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/ol1007718"},{"key":"e_1_3_2_3_22_1","first-page":"288","article-title":"The structure of nojirimycin, a piperidine sugar antibiotic.","volume":"19","author":"Inouye S","year":"1966","unstructured":"Inouye S , TsuroukaT, NiidaT. The structure of nojirimycin, a piperidine sugar antibiotic.J. Antibiot. Ser. A19, 288\u2013292 (1966).","journal-title":"J. Antibiot. Ser. A"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0040-4020(68)88115-3"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1271\/nogeikagaku1924.50.11_571"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059030-00012"},{"key":"e_1_3_2_3_26_1","first-page":"139","article-title":"The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200\u00b1500 CD4 cells\/mm3.","volume":"7","author":"Fischl MA","year":"1994","unstructured":"Fischl MA , ResnickL, CoombsRet al. The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200\u00b1500 CD4 cells\/mm3. J. Acquir. Immune Defic. Syndr. 7, 139\u2013147 (1994).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199106000-00008"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1031527100"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.22.11933-11940.2003"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-6-58"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(00)98636-2"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2003.00293.x"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/jf073223i"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.030288"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0040-4039(94)80134-7"},{"key":"e_1_3_2_3_36_1","first-page":"169","article-title":"Casuarine-6-\u03b1-D-glucoside from Casuarina equisetifolia and Eugenia jambolana.","volume":"2","author":"Wormald MR","year":"1996","unstructured":"Wormald MR , NashRJ, WatsonAAet al. Casuarine-6-\u03b1-D-glucoside from Casuarina equisetifolia and Eugenia jambolana. Carbohydr. Lett. 2, 169\u2013174 (1996).","journal-title":"Carbohydr. Lett."},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152008783330851"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/4801"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"crossref","unstructured":"Fan J -Q. Iminosugars: from Synthesis to Therapeutic Applications. Compain P Martin OR (Eds). Wiley-VCH Weinheim Germany 225\u2013247 (2007).","DOI":"10.1002\/9780470517437.ch10"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-1077-0"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.04.048"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.53"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605928103"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(86)90046-9"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200800350"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0495881"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetasy.2004.11.067"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.03.010"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2009.53"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.071050798"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.15.12.1601"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetasy.2009.03.013"},{"key":"e_1_3_2_4_2_1","unstructured":"Watson AA Nash RJ Evinson E: WO064715 (2004)."},{"key":"e_1_3_2_4_3_1","doi-asserted-by":"crossref","unstructured":"Summit Corporation Plc.: WO066069 (2008).","DOI":"10.3833\/pdr.v2008i92.226"},{"key":"e_1_3_2_4_4_1","doi-asserted-by":"crossref","unstructured":"Summit Corporation Plc.: WO009894 (2008).","DOI":"10.3833\/pdr.v2008i92.226"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc.11.117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T15:50:14Z","timestamp":1716479414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc.11.117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.4155\/fmc.11.117"],"URL":"https:\/\/doi.org\/10.4155\/fmc.11.117","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}